Anna Clark, MD
Dermatology · Newport News, VANPI 1457705733
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 1,015 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Among dermatology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,015 payments — averaging $16.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Pfizer$1K
- Galderma Laboratories, L.p.$994
- Regeneron Healthcare Solutions, Inc.$961
- LEO Pharma Inc.$947
- Lilly USA, LLC$882
- plus $9K from 31 others
What the payments were for
- Food & beverage$16,75198%
- Education$3782%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 232 | $3,520 |
| Pfizer | 97 | $1,157 |
| Galderma Laboratories, L.p. | 47 | $994 |
| Regeneron Healthcare Solutions, Inc. | 29 | $961 |
| LEO Pharma Inc. | 69 | $947 |
| Lilly USA, LLC | 53 | $882 |
| Amgen | 36 | $865 |
| UCB, Inc. | 42 | $794 |
| Incyte Corporation | 47 | $787 |
| Johnson & Johnson | 29 | $708 |
| Dermavant Sciences, Inc. | 74 | $706 |
| Arcutis Biotherapeutics, Inc. | 42 | $559 |
| Novartis | 23 | $548 |
| Sun Pharmaceutical Industries Inc. | 22 | $539 |
| E.r. Squibb & Sons, L.L.C. | 31 | $476 |
| Almirall LLC | 30 | $407 |
| Mayne Pharma Commercial LLC | 29 | $392 |
| Sanofi | 14 | $322 |
| Kerecis Limited | 4 | $285 |
| Botanix SB Inc | 23 | $234 |
| Genentech USA, Inc. | 1 | $150 |
| Boehringer Ingelheim | 2 | $137 |
| Janssen Scientific Affairs, LLC | 1 | $124 |
| Journey Medical Corporation | 6 | $114 |
| Biofrontera Inc. | 5 | $81 |
| Sanofi-aventis U.S. LLC | 1 | $72 |
| Mallinckrodt Hospital Products Inc. | 3 | $66 |
| Organon | 9 | $56 |
| VYNE Pharmaceuticals Inc. | 3 | $52 |
| ANI Pharmaceuticals, Inc. | 2 | $49 |
| Dermira, Inc. | 2 | $33 |
| EPI Health, LLC | 2 | $29 |
| Sandoz | 1 | $24 |
| Kyowa Kirin, Inc. | 1 | $17 |
| Acelrx Pharmaceuticals, Inc. | 1 | $14 |
| Fresenius Kabi USA, LLC | 1 | $14 |
| Fidia Pharma USA Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 SurgiClose$665
- VTAMA$249
- LIBTAYO$245
- Kerecis Omega3 GraftGuide$222
- Kerecis Omega3 Marigen$222
- XOLAIR$150
- AKLIEF$140
- EPIDUO FORTE$140
- ORACEA$140
- SOFDRA$138
- EPSOLAY$134
- Tremfya$124
- Rinvoq$123
- SPEVIGO$111
- OPZELURA$109
- Otezla$107
How this compares
$17,129 in reported general payments places this provider in the 90th percentile of 396 dermatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 11 | $149,857 |
| Tretinoin | 41 | $3,522 |
| Clobetasol Propionate | 55 | $2,826 |
| Fluorouracil | 33 | $2,285 |
| Fluocinonide | 49 | $1,966 |
| Betamethasone Dipropionate | 21 | $1,860 |
| Mycophenolate Mofetil | 12 | $1,067 |
| Triamcinolone Acetonide | 124 | $991 |
| Metronidazole | 14 | $816 |
| Ketoconazole | 51 | $725 |
| Doxycycline Hyclate | 55 | $660 |
| ValacyclovirValacyclovir Hcl | 41 | $378 |
| Mupirocin | 41 | $341 |
| Fluconazole | 19 | $260 |
| Clindamycin Phosphate | 11 | $212 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Newport News
- Valerie HarveyNewport News$26K
- Laine KochNewport News$16K
- Naiem IssaVienna$2M
- Saurabh SinghFairfax$1.7M
- Diego DasilvaVirginia Beach$1.1M
- Vishal PatelLeesburg$719K
- Cyndi Torosky TommasoVirginia Beach$717K
- Daniel HurdBlacksburg$545K
- Jonathan SchreiberNorfolk$330K
- Robert BaerSuffolk$303K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.